Inactive Instrument
AS Olainfarm Share Price Deutsche Boerse AG
Stocks
UU4
LV0000100501
Pharmaceuticals
| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 31/12/2025 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 31/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 18/06/2021 | |
Janis Buks
CHM | Chairman | - | 31/08/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 148M | |
| +1.81% | +2.25% | +13.40% | +84.45% | 48B | |
| -2.54% | +3.72% | +65.71% | +113.61% | 36.89B | |
| +0.15% | +1.26% | -3.35% | +45.56% | 12.37B | |
| +3.71% | +3.56% | +14.13% | +97.20% | 11.95B | |
| +0.39% | +0.58% | +33.25% | +119.07% | 9.01B | |
| +0.66% | -0.57% | +19.28% | +45.55% | 7.2B | |
| +0.71% | +1.75% | +53.59% | -7.09% | 7.05B | |
| +0.68% | +2.63% | +23.97% | +235.28% | 6.55B | |
| +9.99% | +32.94% | -15.69% | +27.08% | 6.58B | |
| Average | +1.53% | +4.24% | +22.70% | +84.52% | 16.18B | |
| Weighted average by Cap. | +0.84% | +3.35% | +27.92% | +89.56% |
Employees
2,191
Sector
Pharmaceuticals
